These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26599571)

  • 21. MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.
    Jiang F; Zhao W; Zhou L; Liu Z; Li W; Yu D
    Int J Mol Sci; 2014 Dec; 15(12):22128-41. PubMed ID: 25474084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.
    Du Y; Zhu M; Zhou X; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
    Tumour Biol; 2016 Jan; 37(1):1261-9. PubMed ID: 26286834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
    Cheng MW; Shen ZT; Hu GY; Luo LG
    Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-183-5p-PNPT1 Axis Enhances Cisplatin-induced Apoptosis in Bladder Cancer Cells.
    Hu QG; Yang Z; Chen JW; Kazobinka G; Tian L; Li WC
    Curr Med Sci; 2022 Aug; 42(4):785-796. PubMed ID: 35788944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway.
    Bu Q; Fang Y; Cao Y; Chen Q; Liu Y
    Mol Med Rep; 2014 Oct; 10(4):2203-9. PubMed ID: 25109742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT.
    Zhou J; Dai W; Song J
    Biochem Biophys Res Commun; 2016 Feb; 470(2):445-452. PubMed ID: 26772886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
    Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-150 modulates cisplatin chemosensitivity and invasiveness of muscle-invasive bladder cancer cells via targeting PDCD4 in vitro.
    Lei Y; Hu X; Li B; Peng M; Tong S; Zu X; Wang Z; Qi L; Chen M
    Med Sci Monit; 2014 Oct; 20():1850-7. PubMed ID: 25287716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.
    Yamasaki T; Yoshino H; Enokida H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Fuse M; Seki N; Nakagawa M
    Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA‑138 expression.
    Wu J; Wang L; Du X; Sun Q; Wang Y; Li M; Zang W; Liu K; Zhao G
    Oncol Rep; 2018 Mar; 39(3):1163-1172. PubMed ID: 29328459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.
    Krafft U; Tschirdewahn S; Hess J; Harke NN; Hadaschik B; Olah C; Krege S; Nyirády P; Szendröi A; Szücs M; Módos O; Székely E; Reis H; Szarvas T
    Urol Oncol; 2019 Nov; 37(11):810.e7-810.e15. PubMed ID: 31053526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
    Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
    FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators.
    Steele TM; Talbott GC; Sam A; Tepper CG; Ghosh PM; Vinall RL
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA‑26a‑5p and miR‑26b‑5p inhibit the proliferation of bladder cancer cells by regulating PDCD10.
    Wu K; Mu XY; Jiang JT; Tan MY; Wang RJ; Zhou WJ; Wang X; He YY; Li MQ; Liu ZH
    Oncol Rep; 2018 Dec; 40(6):3523-3532. PubMed ID: 30272373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
    Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
    Wang S; Li H; Wang J; Wang D; Yao A; Li Q
    Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.
    Inoguchi S; Seki N; Chiyomaru T; Ishihara T; Matsushita R; Mataki H; Itesako T; Tatarano S; Yoshino H; Goto Y; Nishikawa R; Nakagawa M; Enokida H
    FEBS Lett; 2014 Aug; 588(17):3170-9. PubMed ID: 24999187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.
    Alajez NM; Lenarduzzi M; Ito E; Hui AB; Shi W; Bruce J; Yue S; Huang SH; Xu W; Waldron J; O'Sullivan B; Liu FF
    Cancer Res; 2011 Mar; 71(6):2381-91. PubMed ID: 21385904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells.
    Zhang F; Wu H
    Biochem Biophys Res Commun; 2021 Sep; 570():154-161. PubMed ID: 34284141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.